Exacting Extractions

"Innovation is our mission," states Rockford, Ill.-based Pierce Chemical Company's Rick Chu. True to those words, Chu has applied Pierce's expertise in detergent chemistry to the development of a family of protein extraction reagents designed to rapidly and efficiently extract proteins from bacteria, yeast, and mammalian cell lines. Cell lysis, of course, is an important first step in recovering recombinant proteins or for providing samples for various assays. The new Pierce protein extraction

Written byMichael Brush
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"Innovation is our mission," states Rockford, Ill.-based Pierce Chemical Company's Rick Chu. True to those words, Chu has applied Pierce's expertise in detergent chemistry to the development of a family of protein extraction reagents designed to rapidly and efficiently extract proteins from bacteria, yeast, and mammalian cell lines. Cell lysis, of course, is an important first step in recovering recombinant proteins or for providing samples for various assays. The new Pierce protein extraction reagents provide a gentle means of cell lysis that is not detrimental to the protein of interest.

The first-born member of this family, the B-PER Bacterial Protein Extraction Reagent, consists of a proprietary nonionic detergent in 20 mM Tris*HCl buffer (pH 7.5). In use, a 10- to 20-fold volume of B-PER™ Reagent is added to a bacterial pellet and shaken for 10 minutes. Soluble proteins are then recovered by a centrifugation step, and inclusion bodies are purified ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies